111 related articles for article (PubMed ID: 16456550)
1. Endostatin therapy reveals a U-shaped curve for antitumor activity.
Tjin Tham Sjin RM; Naspinski J; Birsner AE; Li C; Chan R; Lo KM; Gillies S; Zurakowski D; Folkman J; Samulski J; Javaherian K
Cancer Gene Ther; 2006 Jun; 13(6):619-27. PubMed ID: 16456550
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
3. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J
Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis and tumor progression by hydrodynamic cotransfection of angiostatin K1-3, endostatin, and saxatilin genes.
Kim KS; Kim DS; Chung KH; Park YS
Cancer Gene Ther; 2006 Jun; 13(6):563-71. PubMed ID: 16410825
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model.
Lai LJ; Xiao X; Wu JH
J Biomed Sci; 2007 May; 14(3):313-22. PubMed ID: 17373573
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal gene therapy by rAAV provides long-term survival against epithelial ovarian cancer independently of survivin pathway.
Isayeva T; Ren C; Ponnazhagan S
Gene Ther; 2007 Jan; 14(2):138-46. PubMed ID: 16943851
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors.
Zhu LP; Xing J; Wang QX; Kou L; Li C; Hu B; Wu ZW; Wang JJ; Xu GX
Eur J Pharmacol; 2009 Sep; 617(1-3):23-7. PubMed ID: 19615993
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve.
Celik I; Sürücü O; Dietz C; Heymach JV; Force J; Höschele I; Becker CM; Folkman J; Kisker O
Cancer Res; 2005 Dec; 65(23):11044-50. PubMed ID: 16322254
[TBL] [Abstract][Full Text] [Related]
9. [Research of the anti-tumor effect of human endostatin mediated by recombinant adeno-associated virus].
Lu GQ; Zha YY; Wu XB; Yang JG; Zhang XY; Fu M; Liang X; Wu M; Lin C
Ai Zheng; 2002 Dec; 21(12):1314-8. PubMed ID: 12520738
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo.
Shi W; Teschendorf C; Muzyczka N; Siemann DW
Cancer Gene Ther; 2002 Jun; 9(6):513-21. PubMed ID: 12032662
[TBL] [Abstract][Full Text] [Related]
11. [Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: experiments in vitro and in vivo].
Lu BX; Han RF; Tang Y; Han YZ; Li SZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):802-5. PubMed ID: 17565858
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated viral vector-mediated expression of endostatin inhibits tumor growth and metastasis in an orthotropic pancreatic cancer model in hamsters.
Noro T; Miyake K; Suzuki-Miyake N; Igarashi T; Uchida E; Misawa T; Yamazaki Y; Shimada T
Cancer Res; 2004 Oct; 64(20):7486-90. PubMed ID: 15492274
[TBL] [Abstract][Full Text] [Related]
13. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
[TBL] [Abstract][Full Text] [Related]
14. Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy.
Lee TY; Tjin Tham Sjin RM; Movahedi S; Ahmed B; Pravda EA; Lo KM; Gillies SD; Folkman J; Javaherian K
Clin Cancer Res; 2008 Mar; 14(5):1487-93. PubMed ID: 18316573
[TBL] [Abstract][Full Text] [Related]
15. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
Kulke MH; Bergsland EK; Ryan DP; Enzinger PC; Lynch TJ; Zhu AX; Meyerhardt JA; Heymach JV; Fogler WE; Sidor C; Michelini A; Kinsella K; Venook AP; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3555-61. PubMed ID: 16877721
[TBL] [Abstract][Full Text] [Related]
17. Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy.
Su C; Na M; Chen J; Wang X; Liu Y; Wang W; Zhang Q; Li L; Long J; Liu X; Wu M; Fan X; Qian Q
Mol Cancer Res; 2008 Apr; 6(4):568-75. PubMed ID: 18344493
[TBL] [Abstract][Full Text] [Related]
18. [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice].
Liu FJ; Tan G; Li J; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2147-51. PubMed ID: 19080480
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of an established A431 xenograft tumor by a full-length anti-EGFR antibody following gene delivery by AAV.
Ho DT; Wykoff-Clary S; Gross CS; Schneider D; Jin F; Kretschmer PJ; Hermiston TW
Cancer Gene Ther; 2009 Feb; 16(2):184-94. PubMed ID: 18758433
[TBL] [Abstract][Full Text] [Related]
20. [Clinical tolerance trial on recombinant human endostatin adenovirus].
Cao Y; Li S; Li HL; Li YH; Zhang DS; Guo Y; Li XL; Lin XB; Huang WL; Jiang WQ
Ai Zheng; 2007 Aug; 26(8):856-60. PubMed ID: 17697547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
